These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7179272)

  • 1. Long-term follow-up of patients who have undergone valve replacements for acquired valvular disease: a clinical and hemodynamic study.
    Tabayashi K; Kagawa Y; Abe Y; Yokoyama A; Onodera H; Horiuchi T
    Tohoku J Exp Med; 1982 Oct; 138(2):209-22. PubMed ID: 7179272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long term follow-up of the patients underwent valve replacements for acquired valvular disease--clinical and hemodynamic study (author's transl)].
    Tabayashi K
    Nihon Kyobu Geka Gakkai Zasshi; 1981 Mar; 29(3):348-59. PubMed ID: 7252272
    [No Abstract]   [Full Text] [Related]  

  • 3. [When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?].
    Acar J; Michel PL; de Gevigney G
    Presse Med; 2000 Nov; 29(34):1867-75. PubMed ID: 11709821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic changes after valve replacement with Starr-Edwards prostheses.
    Bristow JD; Kremkau EL
    Am J Cardiol; 1975 May; 35(5):716-24. PubMed ID: 1124728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central haemodynamics at rest and during exercise before and after combined aortic and mitral valve replacement with the Björk-Shiley tilting disc valve prosthesis.
    Aberg B; Jonasson R
    Scand J Thorac Cardiovasc Surg; 1980; 14(1):21-32. PubMed ID: 7375888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of muscle relaxant drugs during anesthetic induction in patients with mitral or aortic valvular heart disease.
    Larach DR; Hensley FA; Martin DE; High KM; Rung GW; Skeehan TM
    J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):126-31. PubMed ID: 1677822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic predictors of outcome in patients undergoing valve replacement.
    Carabello BA; Williams H; Gash AK; Kent R; Belber D; Maurer A; Siegel J; Blasius K; Spann JF
    Circulation; 1986 Dec; 74(6):1309-16. PubMed ID: 3779916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and concomitant factors of tricuspid valve insufficiency in patients with aortic and mitral valve diseases].
    Dittmann H; Weinmann M; Unterberg R; Karsch KR
    Z Kardiol; 1989 Jun; 78(6):380-5. PubMed ID: 2756734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative therapy using human atrial natriuretic peptide in cases of valve replacement].
    Maeda T; Kitamura M; Kawai A; Hachida M; Aomi S; Endo M; Koyanagi H; Sakomura Y; Matsuda N; Kasanori H
    Jpn J Thorac Cardiovasc Surg; 1998 Dec; 46(12):1297-304. PubMed ID: 10037839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of patients with heart defects. When is a new valve needed?].
    Stiefelhagen P
    MMW Fortschr Med; 2004 Sep; 146(40):4-6, 8. PubMed ID: 15529658
    [No Abstract]   [Full Text] [Related]  

  • 11. Echocardiographic studies of left ventricular wall motion and dimensions after valvular heart surgery.
    Burggraf GW; Craige E
    Am J Cardiol; 1975 Apr; 35(4):473-80. PubMed ID: 1119397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional impact of transmitral gradients at rest and during exercise after restrictive annuloplasty for ischemic mitral regurgitation.
    Bertrand PB; Gutermann H; Smeets CJ; Van Kerrebroeck C; Verhaert D; Vandervoort P; Dion R
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):183-7. PubMed ID: 24332186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate hemodynamic response to correction of cardiac valvular lesions.
    Carey JS; Plested WG
    Ann Thorac Surg; 1972 Apr; 13(4):311-23. PubMed ID: 5019856
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative markers of postoperative persistent severe left ventricular dysfunction.
    Rudolph W; Kraus F; Rudolph C
    Z Kardiol; 1986; 75 Suppl 2():90-4. PubMed ID: 3727723
    [No Abstract]   [Full Text] [Related]  

  • 15. Should valvular replacement be reserved for symptomatic valvular heart disease?
    Rapaport E
    Cardiovasc Clin; 1977; 8(1):269-77. PubMed ID: 849595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Different rates of progression of heart valve defects].
    Schuler G; Hambrecht R; Farahmandi R; Kübler W
    Z Kardiol; 1991 Jan; 80(1):44-50. PubMed ID: 2035286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of functional classification of hemodynamic disorders in cardiac surgical patients with heart defects].
    Kudriashev VE; Beletskiĭ IuV; Dobrovol'skaia TN
    Khirurgiia (Mosk); 1990 May; (5):30-4. PubMed ID: 2391934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exercise capacity after heart valve replacement].
    Horstkotte D; Niehues R; Schulte HD; Strauer BE
    Z Kardiol; 1994; 83 Suppl 3():111-20. PubMed ID: 7941657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Panel discussion: Evaluation of cardiac function for valve replacement].
    J Cardiol Suppl; 1989; 20():5-8. PubMed ID: 2605006
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of various mechanical heart values in the mitral and aortic positions.
    Iwahashi K; Ota T; Okada M; Tsukube T; Matsuda H
    Kobe J Med Sci; 1993 Jun; 39(3):81-93. PubMed ID: 8255076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.